









Markets
/
Stocks
/
nasdaq-zjyl
/

Jin Medical International Ltd

ZJYL

0.209USD

+0.001+0.29%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

32.69MMarket Cap

18.24P/E TTM



Jin Medical International Ltd

0.209

+0.001+0.29%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Jin Medical International Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-446.45%-1.26M

-98.18%50.00K

--362.91K

--2.74M

Net income from continuing operations

54.28%1.72M

-3.51%1.70M

--1.11M

--1.77M

Operating gains losses

59.71%177.98K

46.90%168.15K

--111.44K

--114.47K

Deferred tax

-40.03%12.62K

-65.42%23.71K

--21.04K

--68.56K

Other non-cash items

113.22%6.77K

-157.88%-99.28K

---51.19K

--171.52K

Change in working capital

-285.24%-3.17M

-381.25%-1.75M

---822.88K

--622.08K

-Change in receivables

-960.68%-2.88M

-882.52%-1.02M

---271.79K

---104.29K

-Change in inventory

-143.88%-486.42K

26.78%566.73K

--1.11M

--447.02K

-Change in prepaid expenses

92.89%-54.32K

-2854.35%-1.31M

---763.86K

--47.50K

-Change in payables and accrued expense

-183.61%-109.21K

806.93%206.42K

---38.51K

---29.20K

-Change in other current assets

----

--0.00

-Change in other current liabilities

-49.73%96.23K

6.54%-159.98K

--191.43K

---171.17K

Cash from non-recurring investing activities

Cash from operating activities

-446.45%-1.26M

-98.18%50.00K

--362.91K

--2.74M

Investing cash flow

Net cash from continuing investing activities

-35.55%59.86K

9649.17%1.06M

--92.89K

--10.91K

Capital expenditures

-40.47%61.27K

9563.81%1.06M

--102.92K

--11.01K

Net cash flow from disposal of fixed assets

-35.55%59.86K

9649.17%1.06M

--92.89K

--10.91K

Net cash flow from investment products

80.00%-1.06M

-218.15%-7.33M

---5.32M

---2.30M

Net cash flow from other investing activities

-189.07%-4.24M

189.07%4.24M

--4.76M

---4.76M

Cash from non-current investing activities

Net cash flow from investing activities

-717.28%-5.36M

41.34%-4.15M

---656.42K

---7.07M

Financing cash flow

Cash flow from continuous financing activities

575.09%5.65M

-25.87%6.00M

---1.19M

--8.10M

Net cash flow from debt Issuance/repayment

-53.47%1.31M

287.58%5.55M

--2.82M

--1.43M

Net cash flow from common stock issuance/repurchase

--0.00

-96.10%312.00K

--0.00

--8.00M

Net cash flow from preferred stock issuance/repurchase

----

100.00%0.00

--0.00

---1.21M

Proceeds from stock option exercised by employees

----

--336.64K

----

Net cash flow from other financing activities

199.78%4.34M

214.87%138.22K

---4.35M

---120.33K

Net cash from non-recurrent financing activities

Net cash from financing activities

575.09%5.65M

-25.87%6.00M

---1.19M

--8.10M

Net cash flow

Beginning cash balance

2.20%8.87M

44.59%6.93M

--8.68M

--4.79M

Current period cash flow changes

57.90%-738.72K

-50.01%1.95M

---1.75M

--3.89M

Effect of exchange rate changes

185.80%233.29K

-66.94%40.34K

---271.90K

--122.00K

Ending cash balance

17.41%8.14M

2.20%8.87M

--6.93M

--8.68M

Free cash flow

-607.17%-1.32M

-137.12%-1.01M

--259.99K

--2.73M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

